Taiho Pharmaceutical Co., Ltd., commonly referred to as Taiho, is a prominent player in the pharmaceutical industry, headquartered in Japan. Established in 1963, the company has made significant strides in oncology, urology, and other therapeutic areas, positioning itself as a leader in innovative drug development. With a strong operational presence in Japan and expanding markets across Asia and the United States, Taiho is renowned for its commitment to research and development. The company’s core products, including anti-cancer agents and supportive care medications, are distinguished by their efficacy and safety profiles. Taiho's dedication to advancing healthcare has earned it notable achievements, including partnerships with global pharmaceutical firms and recognition for its contributions to cancer treatment. As it continues to grow, Taiho remains focused on delivering high-quality healthcare solutions that meet the evolving needs of patients worldwide.
We don't have data for Taiho Pharmaceutical Co, but we can show you information about their parent organization instead.
View parent company